Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 May 2018 | Story Rulanzen Martin | Photo Rulanzen Martin
Future of MT Steyn statue discussed-Prof Johann Rossouw and Dr Luvuyo Dondolo
Prof Johann Rossouw and Dr Luvuyo Dondolo were also on the panel.

The Faculty of the Humanities hosted a panel discussion on the future of the MT Steyn statue on the Bloemfontein Campus of the University of the Free State (UFS). Panellists who came from diverse backgrounds with opposing viewpoints discussed the current position of the statue in front of the Main Building on the campus.

Panellists included academics, student leaders and activists as well as government representatives. They were, Prof Johann Rossouw from the UFS Department of Philosophy; Asive Dlanjwa, SRC president; Mohama Dipolo and Jani Swart, both UFS postgraduate students; Prof Matie Hoffman from the Department of Physics; Mr Ben Mazinga from the South African Heritage Resource Agency(SAHRA); Kelebohile Palane, a UFS student; and Dr Luvuyo Dondolo.

A special task team made a submission to the Free State Heritage Resources Authority (FSHRA). They proposed three options   to cover the statue, fence it, as well use it as a point of engagement. The FSHRA proposed that the statue become a point of engagement. “That is why the Faculty of Humanities decided to host the panel discussion. We are Humanities and we have to talk about it,” said Prof Heidi Hudson, Dean of the faculty. 

The panel discussion took place on 29 May 2018 and was facilitated by Mr Willem Ellis, research fellow at the Centre for Gender and Africa Studies.


An old conversation on future of the Steyn statue

The first speaker, Dr Dondolo, said MT Steyn was a symbol of Afrikaner nationalism. “The values Steyn represents and the values of the UFS and South Africa do not correlate,” he said. Prof Rossouw added that the Steyn statue stood in the way of healing and transformation. 

SRC president Dlanjwa said conversations regarding the statue had started back in 2015 and it was not a new discussion on its future.  

“We are covering the statue because it is a subject under discussion but we have unfortunately lost that battle,” he said. He added: “The removal of the statue has nothing to do with purging a particular section of society. It has everything to do with recognising the existence and humanity of the people that share the space of the UFS.” 

Dipolo said: “We must move away from historical figures to something non-offensive.” This was a step to transform public spaces. 

Mr Mazinga said there had to be an alternative perspective regarding the debate. “It shouldn’t necessarily be about removing, but to also speak to an alternative past.” It was important to transform public spaces as there was an over-representation of one group from the past, he said.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept